Estimating LFT and qPCR test-sensitivity over time since infection from a human challenge study
Davis, E. L.; Hollingsworth, D.
Show abstract
Testing has been central to global policy throughout the SARS-CoV-2 pandemic. Understanding how test sensitivity changes after exposure is crucial for the interpretation of test outcomes and the design of testing-based interventions. Using data from a human challenge study, we derive temporal test sensitivity profiles for lateral flow tests (LFT), quantitative polymerase chain reaction (qPCR) tests and viable virus, measured by focus-forming assay (FFA). The median time to detectability was 2 days (throat swab) and 3 days (nasal) for qPCR and 4 days for LFT (both swabs), and there was strong positive correlation between first LFT positive and first FFA positive for both throat (p=0.00019) and nasal (p=0.00032) swabs, supporting the use of LFTs as a method of detecting infectiousness. Peak LFT sensitivity was 82.4% (67.0%-91.8%) for throat samples, occurring 6 days post-exposure and 93.3% (85.1%-98.0%) for nasal, 7 days post-exposure. These temporal profiles provide quantification of the mean behaviour of these tests and individual-based variability and could inform a framework for investigating future testing-based interventions.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission 93%
- Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay 92%
- Utility of Pan-Family Assays for Rapid Viral Screening: Reducing Delays in Public Health Responses During Pandemics 92%
Similar papers in this journal
Similar papers in this journal
- Comparative performance of SARS CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimens 93%
- Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity 92%
- Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation 90%
Similar papers in this journal
- Transmission dynamics of Norovirus GII and Enterovirus in Switzerland during the COVID-19 pandemic (2021-2022) as evidenced in wastewater 92%
- Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland 92%
- Cross-sectional cycle threshold values reflect epidemic dynamics of COVID-19 in Madagascar 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.